re: #41 Renaissance_Man

Absolutely. It’s a common rort - make a new disease that you can then rebrand an old drug for as ‘treating’ it and resell it all over again. If you’re lucky you can get a whole new patent for the same drug, thus guaranteeing many more years of extreme markups without the drug going generic. At the very least, you get a whole new campaign to push for more prescriptions for your drug.

I see how that is a benefit for drug companies, but what about women who have severe PMS? Should it not have a separate name, and different treatment? Is that all “PMDD” is, really?